Telik, Inc. Financial Statements
Telik, Inc. Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Telik, Inc. Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (60.3) | (87.8) | (82.6) |
| Total Net Income ($ mil.) | (55.2) | (79.6) | (75.5) |
| Diluted EPS (Net Income) | (1.05) | (1.52) | (1.47) |
Telik, Inc. Quarterly Statements
| Quarter Ending Sep 08 | Quarter Ending Jun 08 | Quarter Ending Mar 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (7.8) | (11.0) | (10.6) |
| Total Net Income ($ mil.) | (8.0) | (13.6) | (9.8) |
| Diluted EPS (Net Income) | (0.15) | (0.25) | (0.19) |
Telik, Inc. Stock Quote & Chart
12/02/08 14:07:32 EST •
NASDAQ •
0.19
•
 -0.0227
•
-10.8095 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Telik, Inc. Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 2.19 | 0.94 |
| Price/Earnings Ratio | -- | 10.78 | 10.50 |
| Price/Book Ratio | 0.15 | 1.67 | 0.89 |
| Price/Cash Flow Ratio | -- | 8.97 | 5.93 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Telik, Inc. Financial Ratios
Telik, Inc. Competitive Intelligence
| Amgen | Bristol-Myers Squibb | Genentech | |
|---|---|---|---|
| Annual Sales ($ mil.) | 14,771.0 | 19,348.0 | 11,724.0 |
| Employees | 17,500 | 42,000 | 11,174 |
| Market Cap ($ mil.) | 58,139.1 | 40,720.6 | 76,525.0 |
Competitive Landscape
